Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-24

Clinical Trial Update: Population Pharmacokinetics of Remifentanil in Low-Weight Critically Ill Patients

View source ↗

Summary

A population pharmacokinetics study of remifentanil in low-weight critically ill patients is currently recruiting to improve dosing guidance in this group.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remifentanil (remifentanil)

Snippet

Sponsor: Fudan University | Conditions: Critical Illness, Pain | Status: RECRUITING